Elan Pharmaceuticals has licensed the Pathway Studio software from Ariadne. Elan is biotechnology company that develops therapies for neurology and autoimmune diseases. It chose Pathway Studio for its advanced text-mining tools, powerful experimental data interpretation and pathway analysis capability.
Ariadne’s Pathway Studio includes the ResNet database of functional relationships that can be used for assembly of biological pathways, exploring signalling networks, and to interpret microarray experimental data. MedScan’s natural language processing technology enables customers to extend ResNet though extraction of pathway-related information from biomedical literature.
Jim Miller, principal scientist at Elan Pharmaceuticals: ‘The MedScan module, in particular, gives a scientist the capability to quickly create pathways from the newest literature sources in a matter of minutes.’